SORAFENIB THERAPY IN THE MANAGEMENT OF ADVANCED RENAL CELL CARCINOMA WITH BRAIN METASTASES: RESULTS FROM THE ARCCS EXPANDED ACCESS PROGRAM

2008 ◽  
Vol 7 (3) ◽  
pp. 245 ◽  
Author(s):  
C.A. Henderson ◽  
R.M. Bukowski ◽  
W.M. Stadler ◽  
J.P. Dutcher ◽  
T.L. Kindwall-Keller ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Brain Metastases ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Sorafenib Therapy ◽  
Access Program

scholarly journals Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Cancer ◽  
2010 ◽  
Vol 116 (5) ◽  
pp. 1272-1280 ◽  
Author(s):  
Walter M. Stadler ◽  
Robert A. Figlin ◽  
David F. McDermott ◽  
Janice P. Dutcher ◽  
Jennifer J. Knox ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
North America ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program

Oncology ◽  
2010 ◽  
Vol 78 (5-6) ◽  
pp. 340-347 ◽  
Author(s):  
Ronald M. Bukowski ◽  
Walter M. Stadler ◽  
David F. McDermott ◽  
Janice P. Dutcher ◽  
Jennifer J. Knox ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Elderly Patients ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Safety And Efficacy ◽  
Expanded Access ◽  
The North ◽  
Expanded Access Program ◽  
Access Program

REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis

2015 ◽  
Vol 11 (21) ◽  
pp. 2893-2903 ◽  
Author(s):  
Sergio Bracarda ◽  
Sylvie Rottey ◽  
Amit Bahl ◽  
Christian Eichelberg ◽  
Begoña Mellado ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Real World Data ◽  
World Data ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)

2018 ◽  
Vol 29 ◽  
pp. viii317
Author(s):  
A. Gomez de Liano Lista ◽  
B. Venugopal ◽  
K. Fife ◽  
S. Symeonides ◽  
N.S. Vasudev ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program
Sign in / Sign up

Export Citation Format

Share Document